Champions Oncology (CSBR) vs Pelthos Therapeutics (PTHS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pelthos Therapeutics (PTHS) has outperformed Champions Oncology (CSBR) over the past year, losing 24.5% versus a loss of 25.4%. Pelthos Therapeutics is the larger company by market cap ($78.5 million vs $69.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CSBR | PTHS |
|---|---|---|
| Share price | $4.98 | $20.50 |
| Market cap | $69.31M | $78.48M |
| 1-day change | +2.05% | -2.33% |
| YTD return | -29.38% | -32.29% |
| 1-year return | -25.38% | -24.47% |
| 5-year return | -51.59% | — |
| Forward P/E | 49.80 | — |
| EPS (TTM) | $-0.07 | $-27.53 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.31 | $37.50 |
| 52-week low | $4.59 | $18.19 |
| Distance from 52-week high | -40.07% | -45.33% |
| Average volume | 11.50K | 59.15K |
| Shares outstanding | 13.92M | 3.83M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CSBR vs PTHS FAQ
Which is bigger, Champions Oncology or Pelthos Therapeutics?
Pelthos Therapeutics (PTHS) is larger, with a market capitalization of $78.48M compared with $69.31M for Champions Oncology (CSBR).
Which stock has performed better over the past year, CSBR or PTHS?
PTHS returned -24.47% over the past 12 months, compared with -25.38% for CSBR (price return, excluding dividends). Past performance does not predict future results.
Are Champions Oncology and Pelthos Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.